Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation AHA 2017

Insights from the FOURIER Trial

Presenter: Marc P. Bonaca

November 15, 2017

Presentation AHA 2017

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Presenter: Kenneth W. Mahaffey

November 14, 2017

Presentation AHA 2017

Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes

Presenter: Louise Bowman

November 14, 2017

Presentation CDM 2017

Can CHD and DM be Prevented? The Answer is on Your Plate

Presenter: Robert A. Vogel

October 05, 2017

Presentation

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

September 15, 2017

Presentation ESC 2017

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

Presenter: Martin J. Holzmann

August 28, 2017

Presentation EuroPCR 2017

BIO-RESORT Silent Diabetes

Presenter: Clemens von Birgelen

May 19, 2017

Presentation EAS 2017

Diet and Cardiometabolic Health

Presenter: Qi Sun

May 03, 2017

Presentation ACC 2017

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

Presenter: Marc Sabatine

March 17, 2017

Presentation SIF 2017

A Case That Went “South-ard”: 63 yo Male p/w progressive

Presenter: Jeffrey A. Southard

March 10, 2017

Presentation JIM 2017

Dedicated Designed DES+ for Diabetic Patients

Presenter: Dinesh Shah

February 10, 2017

Advertisement

Insights from the FOURIER Trial

Canagliflozin for Primary and Secondary Prevention of Cardiovascular Events in Type 2 Diabetes: Results From the CANVAS Program

Effects of Anacetrapib on the Incidence of New-Onset Diabetes Mellitus and on Vascular Events in People With Diabetes

Can CHD and DM be Prevented? The Answer is on Your Plate

Global Geographic Variation in Patient Characteristics in PCI Clinical Trials

PCI vs CABG in Patients with Type 1 Diabetes and Multivessel Disease

BIO-RESORT Silent Diabetes

Diet and Cardiometabolic Health

Further cardiovascular OUtcomes Research with PCSK9 Inhibition in subjects with Elevated Risk

A Case That Went “South-ard”: 63 yo Male p/w progressive

Dedicated Designed DES+ for Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content